Medication Mindfulness: Implementation and Evaluation of a Deprescribing Program for Patients with Chronic Kidney Disease

ACPE Activity Number: 0204-0000-26-070-H05-P
Release Date: 6/16/2026
Expiration Date: 6/16/2029
Activity Type: Knowledge-based
CE Credits: 1 contact hour
Activity Fee: Member – Free / Non-Member – Not Available

This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.

Activity Overview

Polypharmacy is increasingly common in patients living with chronic kidney disease (CKD), yet its risks often go unrecognized in clinical practice. This webinar is designed to equip healthcare professionals with the knowledge and practical skills needed to identify medication-related harms, reduce inappropriate medication use, and improve patient outcomes through safe and effective deprescribing.

Through real‑world patient case scenarios, participants will explore how complex medication regimens can negatively affect safety, kidney function, and overall quality of life. The session will highlight common medication therapy problems seen in chronic disease management, particularly when kidney impairment complicates medication selection, dosing, and monitoring.

Learners will also be guided step‑by‑step through an evidence‑informed deprescribing framework. By breaking down the five key components of the deprescribing process, the webinar will empower clinicians to develop individualized action plans they can apply in their own practice settings.

Join us to strengthen your confidence in managing complex medication regimens and to enhance patient-centered care for individuals with chronic kidney disease.

Accreditation

Target Audience

Learning Objectives

After completing this activity, the learner should be able to:

Describe at least three potential harms associated with polypharmacy in patients with chronic kidney disease (CKD).
State the harmful impact of polypharmacy on patient safety and treatment outcomes.
Identify at least four common medication therapy problems related to the inappropriate use of medications in patients with chronic disease.
Outline the five key steps of the deprescribing process.

Schedule of Activities

Faculty

Relevant Financial Relationship Disclosure

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Methods and CE Requirements

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Online Program

Member

Free

Non-Member

N/A